Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.
Richards T, Rao Baikady R, Clevenger B, et al.
Lancet 2020;396:1353-1361
Review by J. Meier
Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019.
Maatman TK, Jalali F, Feizpour C, et al.
Crit Care Med 2020;48:e783-e790.
Review by C. M. Samama
Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH randomized clinical trial.
Futier E, Garot M, Godet T, et al.
JAMA 2020;323:225-236.
Review by J. Meier
Fibrinogen concentrate to cardiac surgery patients with ongoing bleeding does not increase the risk of thromboembolic complications or death.
Waldén K, Jeppsson A, Nasic S, Karlsson M
Thromb Haemost 2020;120:384-391.
Review by H. B. Ravn
Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials.
Wolf M, Rubin J, Achebe M, et al.
JAMA 2020;323:432-443.
Review by M. Auerbach
Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial.
Tay J, Allan DS, Chatelain E, et al.
J Clin Oncol 2020;38:1463-1473.
Review by M. T. Prochaska
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659